AMGN - Amgen posts late-stage win for Uplizna in immune-mediated disorder
2024-06-05 09:41:38 ET
More on Amgen
- Amgen Is A Fantastic Dividend Growth Stock With A Weight-Loss Wild Card
- Amgen Stock: Poised To Break Out (Technical Analysis)
- Amgen, Inc. (AMGN) ATS and the Approval of IMDELLTRA Conference - (Transcript)
- SA Asks: Which weight-loss stocks should investors be watching?
- Amgen wins approval of first biosimilar of AstraZeneca's Soliris